The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed β-propeller fold
暂无分享,去创建一个
Koji Inaka | Shigeru Sugiyama | Chiaki Fukushima | Hideaki Shima | K. Inaka | S. Sugiyama | R. Shimizu | Ryo Shimizu | A. Yamamoto | C. Fukushima | Atsushi Yamamoto | K. Kyono | H. Hiramatsu | Yutaka Higashiyama | Hajime Hiramatsu | Kiyoshi Kyono | Yutaka Higashiyama | Hideaki Shima | Y. Higashiyama
[1] A. Camargo,et al. Susceptibility of a peptide derived from bradykinin to hydrolysis by brain endo-oligopeptidases and pancreatic proteinases. , 1979, The Journal of biological chemistry.
[2] B. Seed,et al. Cloning and functional expression of the T cell activation antigen CD26. , 1992, Journal of immunology.
[3] L. Polgár. The prolyl oligopeptidase family , 2002, Cellular and Molecular Life Sciences CMLS.
[4] K. Asada,et al. The primary structure of porcine liver acylamino acid-releasing enzyme deduced from cDNA sequences. , 1989, Journal of biochemistry.
[5] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[6] László Polgár,et al. Prolyl Oligopeptidase An Unusual β-Propeller Domain Regulates Proteolysis , 1998, Cell.
[7] G. Piazza,et al. Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. , 1989, The Biochemical journal.
[8] H. Neurath,et al. Evolution of proteolytic enzymes. , 1984, Science.
[9] L. Frohman,et al. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. , 1989, The Journal of clinical investigation.
[10] G. Püschel,et al. Isolation and characterization of dipeptidyl peptidase IV from human placenta. , 1982, European journal of biochemistry.
[11] S. Carr,et al. The structure of TolB, an essential component of the tol-dependent translocation system, and its protein-protein interaction with the translocation domain of colicin E9. , 2000, Structure.
[12] Massimo Paoli,et al. Novel sequences propel familiar folds. , 2002, Structure.
[13] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[14] C. Herrera,et al. The HIV‐1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression , 2000, FEBS letters.
[15] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[16] J. Holst,et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. , 2001, Diabetes.
[17] M. Pacaud,et al. Protease II from Escherichia coli. Purification and characterization. , 1975, The Journal of biological chemistry.
[18] V. Fülöp,et al. Catalysis of serine oligopeptidases is controlled by a gating filter mechanism , 2000, EMBO reports.
[19] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[20] B. McIntyre,et al. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation , 1991, Journal of cellular biochemistry.
[21] W. B. Church,et al. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain. , 1999, European journal of biochemistry.
[22] David T. Jones,et al. β Propellers: structural rigidity and functional diversity , 1999 .
[23] M. Paoli,et al. Protein folds propelled by diversity. , 2001, Progress in biophysics and molecular biology.
[24] Hideaki Shima,et al. Crystallization and preliminary X-ray study of human dipeptidyl peptidase IV (DPPIV). , 2003, Acta crystallographica. Section D, Biological crystallography.